Ross Moat - 30 Oct 2026 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Nov 2026, 18:27:21 UTC
Prior SEC filing
03 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas Barry, Attorney-in-Fact
Filing notes and source

Key filing fact

Ross Moat filed Form 4 for Kiniksa Pharmaceuticals International, plc (KNSA) on 03 Nov 2026.

Key facts

  • This page summarizes Ross Moat's Form 4 filing for Kiniksa Pharmaceuticals International, plc (KNSA).
  • 29 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 03 Nov 2026, 18:27.

Change

  • Previous filing in this sequence was filed on 03 Sep 2026.
  • Current net transaction value: -$9,625,790.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001857177 Primary reporting owner

Moat Ross

Relationship
CHIEF OPERATING OFFICER
Address
C/O KINIKSA PHARMACEUTICALS INT'L, 105 PICCADILLY, SECOND FLOOR, LONDON, UNITED KINGDOM
Signature
/s/ Douglas Barry, Attorney-in-Fact
Signature date
03 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+16,111
Change %
+99%
Price
$10.76*
Shares after
32,418
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+21,059
Change %
+65%
Price
$11.10*
Shares after
53,477
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+3,760
Change %
+7%
Price
$11.97*
Shares after
57,237
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+1,658
Change %
+2.9%
Price
$12.97*
Shares after
58,895
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+16,112
Change %
+27%
Price
$17.76*
Shares after
75,007
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+10,895
Change %
+15%
Price
$18.06*
Shares after
85,902
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$3,475,300
Shares
-37,775
Change %
-44%
Price
$92.00
Shares after
48,127
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1, F2
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$1,402,730
Shares
-15,114
Change %
-31%
Price
$92.81
Shares after
33,013
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1, F3
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$792,167
Shares
-8,430
Change %
-26%
Price
$93.97
Shares after
24,583
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1, F4
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$596,287
Shares
-6,282
Change %
-26%
Price
$94.92
Shares after
18,301
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1, F5
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$352,622
Shares
-3,672
Change %
-20%
Price
$96.03
Shares after
14,629
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1, F6
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$170,896
Shares
-1,760
Change %
-12%
Price
$97.10
Shares after
12,869
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1, F7
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$251,732
Shares
-2,575
Change %
-20%
Price
$97.76
Shares after
10,294
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1, F8
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+9,412
Change %
+91%
Price
$18.06*
Shares after
19,706
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+12,302
Change %
+62%
Price
$21.77*
Shares after
32,008
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+6,263
Change %
+20%
Price
$22.89*
Shares after
38,271
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$609,508
Shares
-6,681
Change %
-17%
Price
$91.23
Shares after
31,590
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1, F9
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$822,191
Shares
-8,932
Change %
-28%
Price
$92.05
Shares after
22,658
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1, F10
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$1,084,452
Shares
-11,642
Change %
-51%
Price
$93.15
Shares after
11,016
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1, F11
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$67,904
Shares
-722
Change %
-6.6%
Price
$94.05
Shares after
10,294
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1, F12

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-16,111
Change %
-69%
Price
$0.000000*
Shares after
7,250
Date
30 Oct 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
16,111
Exercise price
$10.76
Footnotes
F1, F13
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-21,059
Change %
-100%
Price
$0.000000*
Shares after
0
Date
30 Oct 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
21,059
Exercise price
$11.10
Footnotes
F1, F14
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-3,760
Change %
-14%
Price
$0.000000*
Shares after
23,492
Date
30 Oct 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
3,760
Exercise price
$11.97
Footnotes
F1, F14
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-1,658
Change %
-100%
Price
$0.000000*
Shares after
0
Date
30 Oct 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
1,658
Exercise price
$12.97
Footnotes
F1, F14
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-16,112
Change %
-59%
Price
$0.000000*
Shares after
11,277
Date
30 Oct 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
16,112
Exercise price
$17.76
Footnotes
F1, F15
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-10,895
Change %
-30%
Price
$0.000000*
Shares after
25,205
Date
30 Oct 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
10,895
Exercise price
$18.06
Footnotes
F1, F16
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-9,412
Change %
-37%
Price
$0.000000*
Shares after
15,793
Date
02 Nov 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
9,412
Exercise price
$18.06
Footnotes
F1, F16
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-12,302
Change %
-31%
Price
$0.000000*
Shares after
27,062
Date
02 Nov 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
12,302
Exercise price
$21.77
Footnotes
F1, F17
KNSA transaction Derivative

Share Option

Options Exercise

Transaction value
Shares
-6,263
Change %
-79%
Price
$0.000000*
Shares after
1,691
Date
02 Nov 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
6,263
Exercise price
$22.89
Footnotes
F1, F14
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 17 footnotes

Footnote F1

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 29, 2026.

Footnote F2

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $91.36 to $92.35. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F3

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $92.36 to $93.31. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F4

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $93.37 to $94.36. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F5

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $94.375 to $95.215. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F6

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $95.485 to $96.405. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F7

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $96.54 to $97.48. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F8

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $97.60 to $98.30. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F9

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.64 to $91.63. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F10

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $91.64 to $92.525. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F11

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $92.732 to $93.725. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F12

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $93.94 to $94.135. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Footnote F13

The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2023.

Footnote F14

The option is fully vested and exercisable.

Footnote F15

The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.

Footnote F16

The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2024.

Footnote F17

The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .